FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to a pyrrole substituted indolone derivative of formula (I), a pharmaceutical composition, comprising said derivative, and the use of pyrrole substituted indolone derivatives for the treatment of tyrosine kinase receptor mediated diseases, such as tumors.
.
EFFECT: for the treatment of tyrosine kinase receptor mediated diseases, such as tumors.
10 cl, 20 ex, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| NAPHTHALENE CARBOXAMIDE DERIVATIVES AS PROTEIN KINASE AND HISTONE DEACETYLASE INHIBITORS, METHODS FOR PREPARING AND USING THEM | 2010 |
|
RU2497809C2 |
| DIHYDROINDOLONE DERIVATIVES | 2009 |
|
RU2468022C2 |
| SUBSTITUTED INDOL-5-OL DERIVATIVES AND THERAPEUTIC APPLICATIONS THEREOF | 2013 |
|
RU2674249C2 |
| 2,5- OR 2,6-DISUBSTITUTED HYDROQUINONE DERIVATIVES CONTAINING AT LEAST ONE CARBOXY-, SULPHO- OR AMIDO GROUP, USED AS MEDICINAL AGENTS | 2021 |
|
RU2827702C1 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF ACUTE MYELOID LEUKEMIA OR METASTATIC MAMMARY GLAND CANCER | 2018 |
|
RU2763346C2 |
| PROTEIN TYROSINE KINASE ACTIVITY INHIBITORS | 2009 |
|
RU2533827C2 |
| QUINAZOLINONE DERIVATIVE, A METHOD FOR PRODUCTION THEREOF, A PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2017 |
|
RU2730500C2 |
| IMIDAZOPYRIMIDINES AS EED INHIBITORS AND USE THEREOF | 2020 |
|
RU2836176C2 |
| COMPOUNDS FOR INHIBITING KINASE EGFR, METHODS FOR PRODUCTION AND USE THEREOF | 2020 |
|
RU2832925C2 |
| (S)-4-OXO-N-(1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDROBENZO[a]HEPTALEN-7-yl)PENTANAMIDE DERIVATIVE AND ITS USE | 2022 |
|
RU2809516C1 |
